SBIR/STTR Research Award

Reagents to study lysine methylation and proteomic survey of the human methyllysi

Award identifier 32067805064aec8efbdd033f28fac42b93f52487138b1cf3339d443b948249b5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$204,750

Program and phase

SBIR · Phase I

Award year

2008

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PROTECH LABORATORIES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2007-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The study of lysine methylation is an emerging field; tremendous progress has been made in understanding this post-translational modification (PTM) on histones and its roles in epigenetic regulation. Many of the enzymes that methylate or demethylate histones have been identified in the recent years, and deregulation of several of these enzymes has been linked to tumorgenesis. One trend that emerges from the study of PTMs on histones is that many of the enzymes that modif y histones can also modify and regulate the function of nonhistone proteins. Our understanding of lysine methylation on nonhistone proteins is almost non-existent since methylation sites on three eukaryotic proteins have been identified so far. The goals o f this proposal are to develop the necessary tools that will enable the study of lysine methylation and to conduct the first survey of the human methyllysine proteome. We propose strategies to produce pan specific antibodies to the mono-, di-, and trimethy llysine. The generation of pan specific antibodies to the three forms of methyllysine will enable scientists to easily study lysine methylation on any protein. Our strategy to identify methyllysine-containing proteins from HeLa cells is novel in that it in corporates a simple prefractionation of the cell extracts to reduce the complexity of the sample and therefore increase our likelihood to immunoaffinity purify the methyllysine peptides with the pan specific antibodies. The experiments outlined in this pro posal will greatly advance our understanding of the biology of lysine methylation in signal transduction pathways. We envision that pan specific antibodies and the catalog of methyllysine proteins in the human proteome will be foundation for important brea kthroughs in this untapped area of research. Given that deregulation of lysine methylation enzymes have been linked to various human diseases, including cancer, we believe that the tools and discoveries describe in this proposal will lead to future scienti fic breakthroughs that will have a direct impact on human health. PUBLIC HEALTH RELEVANCE: Deregulation of lysine methylation has been linked to various human diseases, including cancer. This proposal outlines the development of much-needed reagent s and methods for the study of lysine methylation. The successful completion of this proposed project will lead the development of important tools for the study of lysine methylation and build the foundation for future scientific discoveries that will have a direct impact on public health.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.